0 items USD 0.00Search
Your search for "ark patent intelligence aflibercept comprehensive patent search" gave back 163042 results.
According to our latest research, the global AI Patent Search market size will reach USD million in 2030, growing at a CAGR of % over the analysis...
Catalog:
GIR
February 2024
Price: USD 3,480.00
The global AI Patent Search market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-...
Catalog:
GIR
February 2024
Price: USD 4,480.00
Aflibercept is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It is an inhibitor of vascular endothelial...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Vascular Endothelial Growth Factor B - Pipeline Review, H2 2019 Summary Vascular Endothelial Growth Factor B (VEGF Related Factor or VEGFB) -...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Macular Edema - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Macular...
Catalog:
Global Markets Direct
November 2018
Price: USD 2,000.00
Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct'...
Catalog:
Global Markets Direct
October 2022
Price: USD 2,500.00
Macular Edema - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Macular...
Catalog:
Global Markets Direct
May 2018
Price: USD 2,000.00
Anti–vascular endothelial growth factor therapy, also known as anti-VEGF therapy or medication, is the use of medications that block vascular...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Anti–vascular endothelial growth factor therapy, also known as anti-VEGF therapy or medication, is the use of medications that block vascular...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Aflibercept is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It is an inhibitor of vascular endothelial...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Aflibercept (Eylea) is a recombinant fusion protein that contains Ig-like domain 2 of VEGFR1 and Ig-like domain 3 of VEGFR2. It forms a fusion...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Zeuterin market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Important bispecific antibody targets are basically in clinical practice, and many momentous bispecific antibodies will be born in the future. The...
Catalog:
AEI
June 2021
Price: USD 3,000.00
